Division of Hematology, University of Washington and Puget Sound Blood Center, Seattle, WA, USA.
Blood. 2013 Jan 3;121(1):38-47. doi: 10.1182/blood-2012-08-448944. Epub 2012 Nov 13.
A mild thrombocytopenia is relatively frequent during pregnancy and has generally no consequences for either the mother or the fetus. Although representing no threat in the majority of patients, thrombocytopenia may result from a range of pathologic conditions requiring closer monitoring and possible therapy. Two clinical scenarios are particularly relevant for their prevalence and the issues relating to their management. The first is the presence of isolated thrombocytopenia and the differential diagnosis between primary immune thrombocytopenia and gestational thrombocytopenia. The second is thrombocytopenia associated with preeclampsia and its look-alikes and their distinction from thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. In this review, we describe a systematic approach to the diagnosis and treatment of these disease entities using a case presentation format. Our discussion includes the antenatal and perinatal management of both the mother and fetus.
妊娠期轻度血小板减少症较为常见,一般不会对母亲或胎儿造成任何影响。尽管在大多数患者中并不构成威胁,但血小板减少症可能由一系列病理状况引起,需要更密切的监测和可能的治疗。两种临床情况尤其与它们的普遍性以及与管理相关的问题有关。第一种是单纯性血小板减少症,需要鉴别原发性免疫性血小板减少症和妊娠期血小板减少症。第二种是与子痫前期及其类似疾病相关的血小板减少症,以及与血栓性血小板减少性紫癜和溶血尿毒综合征的鉴别。在这篇综述中,我们使用病例报告的形式描述了一种系统的诊断和治疗这些疾病的方法。我们的讨论包括母亲和胎儿的产前和围产期管理。